ARTICLE | Clinical News
M40403 regulatory update
March 10, 2008 7:00 AM UTC
FDA granted Orphan Drug designation for M40403 to prevent oral mucositis in cancer patients receiving radiation or chemotherapy. The superoxide dismutase (SOD), which already has Orphan Drug designati...